Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVE.L Regulatory News (EVE)

  • There is currently no data for EVE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Eve Sleep plc: Year-end trading update

21 Jan 2020 07:00

Eve Sleep plc (EVE) Eve Sleep plc: Year-end trading update 21-Jan-2020 / 07:00 GMT/BST Dissemination of a Regulatory Announcement that contains inside information according to REGULATION (EU) No 596/2014 (MAR), transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


Eve Sleep plc ("eve" or the "Company")

 

Year-end trading update

Strategic and operational progress, losses and cash burn reduced in-line with plan

 

eve Sleep, the direct to consumer sleep wellness brand operating in the UK, Ireland (together the 'UK&I') and France announces a trading update for the year ended 31 December 2019.

 

Operational and strategic highlights

eve's premium hybrid product announced as the top scoring mattress by Which? in December 2019;

 

Product and range expansion in-line with the rebuild strategy, with the contribution of non-mattress sales1 increasing by 200 bps in the UK and 600 bps in France;

 

Customer repeat rates1 up 230 bps in the UK&I and 360 bps in France;

 

Signed and launched retail partnerships with Argos, Homebase and Dunelm;

 

Landing of new brand campaign featuring the eve sloth - increasing unprompted awareness by 50%.

 

 

Financial highlights

 

Group revenues in core markets of £23.8 million (2018: £29.3m);

 

43% year-on-year reduction in full year EBITDA losses (£10.8m), ahead of expectations;

 

51% full year reduction in cash burn;

 

Net funds at 31 December 2019 of £8.1m, consisting of £7.8m of net cash and £0.25m of advertising credits with Channel 42;

 

Overheads for the year have reduced by 27% with further run-rate savings in Q4.

 

2019 Trading

 

The Company has continued to progress its rebuild strategy, prioritising long term profitability and cash generation over short-term sales growth and market share gains. Notwithstanding the year on year decline in revenue, the Company has delivered a reduction in EBITDA losses ahead of its plans, along with a halving in the cash burn. This shift towards more efficient marketing and higher quality traffic, coupled with a more streamline cost base has driven a reduction in EBITDA losses for the full year of 43% to approximately £10.8m (2018: £19.2m). This translated into a 51% reduction in cash burn to £10.3m (2018: £20.9m) and a year-end net cash balance of £7.8m, plus £0.25m of advertising credits with Channel 4.

 

2020 outlook

 

In Q4 2019 the Company made significant further cost reductions, which is flowing through to an improving cash-burn and bottom line performance compared to Q1-Q3 2019. Accordingly, management considers that its trading in the last four months of the year is more indicative of its prospects for 2020. In the last four months of the year, the Company has for the first time broken even at the operating level (positive margin contribution after all direct and marketing costs but before overheads).

 

eve plans to publish its full year audited results on 24 March 2020.

 

James Sturrock, CEO of eve Sleep commented: 

"We are delivering on our priorities of reducing losses and stemming cash burn as we prioritise profitability over sales growth at any cost. We continue to create award winning products to improve customer's sleep wellness, as evidenced by our latest Which? Best Buy award for our premium hybrid mattress, while removing unprofitable sales and marketing.

We are well placed to make further significant progress in 2020, with a differentiated brand position, a broader product range than peers and ongoing improvements to the customer experience, supported by a lower cost base, a substantial cash balance and no debt. "

Footnote

1 The split of non-mattress revenues and the customer repeat rate calculations are based on sales made through the eve website, excluding sales made through other channels such as retail partnerships

2 As part of the fund raise in February 2019, the Group raised £0.9m of advertising credits with Channel 4, of which £0.25m is remaining at 31 December 2019

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014.

For enquiries, please contact:

eve Sleep plc

James Sturrock, Chief Executive Officer 

Tim Parfitt, Chief Financial Officer

 

via M7 Communications LTD

finnCap Ltd - Nominated Adviser and Broker

Matt Goode / Hannah Boros - Corporate Finance

Alice Lane - Equity Capital Markets

Tel: +44 (0)20 7220 0500

 

M7 Communications LTD - PR/IR

Mark Reed

Tel: +44(0)7903 089 543

 

 


ISIN:GB00BYWMFT51
Category Code:TST
TIDM:EVE
LEI Code: 2138007BAC29AUXWQE6
Sequence No.:41653
EQS News ID:957439
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
18th Nov 20227:00 amRNSCancellation - ESR 2022 plc
17th Oct 20227:30 amRNSSuspension - Eve Sleep PLC
17th Oct 20227:00 amRNSAppointment of Administrators
28th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
27th Sep 20226:17 pmRNSForm 8.3 - eve Sleep plc
27th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
27th Sep 20227:00 amRNSForm 8.3 - eve Sleep plc
26th Sep 20224:40 pmRNSSecond Price Monitoring Extn
26th Sep 20224:36 pmRNSPrice Monitoring Extension
26th Sep 20227:30 amRNSForm 8.3 - eve Sleep plc
23rd Sep 20229:17 amRNSForm 8.3 - eve Sleep plc
21st Sep 20228:47 amRNSForm 8.3 - eve Sleep plc
20th Sep 20222:05 pmRNSSecond Price Monitoring Extn
20th Sep 20222:00 pmRNSPrice Monitoring Extension
20th Sep 202211:05 amRNSSecond Price Monitoring Extn
20th Sep 202211:00 amRNSPrice Monitoring Extension
20th Sep 20229:51 amRNSForm 8.3 - eve Sleep plc
20th Sep 20227:01 amEQSEve Sleep plc: Interim Results and FSP Update
15th Sep 20225:36 pmRNSForm 8.3 - Eve Sleep Plc
12th Sep 20227:56 amRNSForm 8.3 - eve Sleep plc
5th Sep 202210:24 amRNSForm 8.3 - eve Sleep plc
2nd Sep 20229:54 amRNSForm 8.3 - eve Sleep plc
26th Aug 20225:04 pmRNSForm 8.3 - eve Sleep plc
25th Aug 202212:46 pmRNSForm 8.3 - eve Sleep plc
17th Aug 20228:50 amRNSForm 8.3 - eve Sleep plc
11th Aug 20227:00 amRNSForm 8.3 - eve Sleep plc
9th Aug 20229:18 amRNSForm 8.3 - eve Sleep plc
4th Aug 20222:08 pmRNSForm 8.3 - eve Sleep plc
4th Aug 20222:03 pmRNSForm 8.3 - eve Sleep plc
4th Aug 20221:59 pmRNSForm 8.3 - eve Sleep plc
21st Jul 20227:00 amEQSEve Sleep plc: Trading and FSP Update and Non-Executive Director Board Change
11th Jul 202211:20 amRNSForm 8.3 - eve Sleep plc
11th Jul 20227:00 amRNSForm 8.3 - eve Sleep plc
24th Jun 20223:33 pmGNWForm 8.3 - Octopus Investments - Eve Sleep plc
21st Jun 20228:00 amEQSForm 8.3 - 4 Ventures Limited - Form 8.3
16th Jun 20226:22 pmEQSForm 8.3 - Eve Sleep plc: Paul Pindar Form 8.3
9th Jun 20227:00 amRNSForm 8.3 - eve Sleep plc
7th Jun 20226:05 pmEQSEve Sleep plc: AMENDMENT - PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
7th Jun 20224:24 pmRNSForm 8.3 - eve Sleep plc
7th Jun 20222:06 pmRNSSecond Price Monitoring Extn
7th Jun 20222:00 pmRNSPrice Monitoring Extension
7th Jun 20221:50 pmEQSEve Sleep plc: PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
7th Jun 20229:03 amRNSForm 8 (DD) - eve Sleep plc
6th Jun 20223:09 pmGNWForm 8.3 - Octopus Investments - Eve Sleep plc
6th Jun 20229:05 amRNSSecond Price Monitoring Extn
6th Jun 20229:00 amRNSPrice Monitoring Extension
6th Jun 20227:00 amEQSEve Sleep plc: Review of Strategic Options, Formal Sale Process and Trading Update
19th May 20224:21 pmEQSEve Sleep plc: Result of AGM
16th May 20224:30 pmEQSEve Sleep plc: Posting of 2021 Annual Report and Financial Statements and Notice of Annual General Meeting
3rd May 20223:07 pmEQSEve Sleep plc: Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.